60 Degrees Pharmaceuticals, Inc. (SXTPW) revenue by segment

SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value

$0.03−0.00 (-0.38%)

Close on Oct 30, 2026Market cap $3.31MP/E –Yield –

60 Degrees Pharmaceuticals, Inc. revenue by segment

60 Degrees Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.